Sanofi Adopts FDA-Selected Flu Strains To Ensure Readiness For The 2025-26 Flu Season
Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and delivery of its vaccine portfolio for the 2025 ...
Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?
Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.
OTC Consumer Health Market Positioned For Accelerated Growth With Johnson&Johnson, Abbott Laboratories, Sanofi, Unilever
OTC Consumer Health Market Growth 2025 BURLINGAME, CA, UNITED STATES, March 11, 2025 /EINPresswire / --The Global OTC Consumer Health ...
WMTW on MSN3d
Maine announces settlement to reduce insulin costs
Maine Attorney General Aaron Frey announced a settlement agreement Tuesday with Sanofi-Aventis U.S. following scrutiny over the company’s pricing of insulin products. Sign up for our Newsletters Under ...
Pharmaceutical Technology on MSN3d
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
Innovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.